{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:44:25Z","timestamp":1769633065810,"version":"3.49.0"},"reference-count":35,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,7,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To assess the effect on duration of ventilator dependency of a 42-day tapering course of dexamethasone in very low birth weight neonates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Infants (N = 118) were assigned randomly, within birth weight\/gender strata, to treatment with either a 42-day tapering course of dexamethasone or an equal volume of saline as placebo. Entry criteria were 1) birth weight &amp;lt;1501 g; 2) age between 15 and 25 days; 3) &amp;lt;10% decrease in ventilator settings for 24 hours and Fio2 \u22650.3; 4) absence of patent ductus arteriosus, sepsis, major congenital malformation, congenital heart disease; and 5) no evidence of maternal HIV or hepatitis B infection. The dosage schedule was 0.25 mg\/kg bid for 3 days, then 0.15 mg\/kg bid for 3 days, then a 10% reduction in the dose every 3 days until a dose of 0.1 mg\/kg had been given for 3 days, from which time a dose of 0.1 mg\/kg qod was continued until 42 days after entry. The primary endpoint was the number of days on assisted ventilation after study entry. Secondary outcomes of interest included days on supplemental oxygen, days of hospitalization, and potential adverse effects, such as infection, gastrointestinal bleeding, left ventricular hypertrophy, and severe retinopathy of prematurity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Infants in the dexamethasone- and placebo-treated groups were similar in terms of baseline attributes, including birth weight, gestational age, gender, race, and ventilator settings at entry. Infants treated with dexamethasone were on assisted ventilation and supplemental oxygen for fewer days after study entry (median days on ventilator, 5th and 95th percentiles, 13 [1\u201364] vs 25 [6\u2013104]; days on oxygen, 59 [6\u2013247] vs 100 [11\u2013346]). No differences were found in risk of death, infection, or severe retinopathy. In subgroup analyses, the association of dexamethasone with more rapid weaning from the ventilator was weaker among infants enrolled before the 16th day of life, infants with chest radiographs showing cystic changes and\/or hyperinflation, and infants requiring an Fio2 \u22650.7 or a peak inspiratory pressure \u226519 at study entry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions.<\/jats:title><jats:p>A 42-day tapering course of dexamethasone decreases the duration of ventilator and oxygen dependency in very low birth weight infants and is not associated with an increased risk of short-term adverse effects.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.104.1.22","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:45:45Z","timestamp":1092440745000},"page":"22-27","source":"Crossref","is-referenced-by-count":80,"title":["Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants"],"prefix":"10.1542","volume":"104","author":[{"given":"Jamanadas M.","family":"Kothadia","sequence":"first","affiliation":[{"name":"From the Departments of Pediatrics,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Michael","family":"O'Shea","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dia","family":"Roberts","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam T.","family":"Auringer","sequence":"additional","affiliation":[{"name":"Radiology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Grey","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"III\u00a7; and Robert G.","family":"Dillard","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[1999,7,1]]},"reference":[{"key":"2021121003001637500_B1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1542\/peds.87.5.587","article-title":"Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network.","volume":"87","author":"Hack","year":"1991","journal-title":"Pediatrics."},{"key":"2021121003001637500_B2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1542\/peds.75.1.106","article-title":"Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia.","volume":"75","author":"Avery","year":"1985","journal-title":"Pediatrics."},{"key":"2021121003001637500_B3","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM198906083202301","article-title":"A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.","volume":"320","author":"Cummings","year":"1989","journal-title":"N Engl J Med."},{"key":"2021121003001637500_B4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0022-3476(89)80754-1","article-title":"Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial.","volume":"115","author":"Harkavy","year":"1989","journal-title":"J Pediatr."},{"key":"2021121003001637500_B5","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.86.5.722","article-title":"Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.","volume":"86","author":"Kazzi","year":"1990","journal-title":"Pediatrics."},{"key":"2021121003001637500_B6","first-page":"421","article-title":"Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial.","volume":"88","author":"Collaborative Dexamethasone Trial Group","year":"1991","journal-title":"Pediatrics."},{"key":"2021121003001637500_B7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1651-2227.1992.tb12096.x","article-title":"Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease.","volume":"81","author":"Ohlsson","year":"1992","journal-title":"Acta Paediatr."},{"key":"2021121003001637500_B8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1542\/peds.95.4.584","article-title":"Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.","volume":"95","author":"Durand","year":"1995","journal-title":"Pediatrics."},{"key":"2021121003001637500_B9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0022-3476(05)80547-5","article-title":"Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study.","volume":"117","author":"Yeh","year":"1990","journal-title":"J Pediatr."},{"key":"2021121003001637500_B10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1542\/peds.98.2.204","article-title":"A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.","volume":"98","author":"Rastogi","year":"1996","journal-title":"Pediatrics."},{"key":"2021121003001637500_B11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0022-3476(95)70410-8","article-title":"Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant.","volume":"126","author":"Brozanski","year":"1995","journal-title":"J Pediatr."},{"key":"2021121003001637500_B12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/adc.68.5_Spec_No.566","article-title":"Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.","volume":"68","author":"Kari","year":"1993","journal-title":"Arch Dis Child."},{"key":"2021121003001637500_B13","doi-asserted-by":"crossref","first-page":"F33","DOI":"10.1136\/fn.74.1.F33","article-title":"Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome.","volume":"74","author":"Shinwell","year":"1996","journal-title":"Arch Dis Child."},{"key":"2021121003001637500_B14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1203\/00006450-199407001-00022","article-title":"Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome.","volume":"36","author":"Sanders","year":"1994","journal-title":"Pediatr Res."},{"key":"2021121003001637500_B15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1542\/peds.90.4.529","article-title":"Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia.","volume":"90","author":"Sobel","year":"1992","journal-title":"Pediatrics."},{"key":"2021121003001637500_B16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1542\/peds.90.4.534","article-title":"Severe retinopathy of prematurity and steroid exposure.","volume":"90","author":"Batton","year":"1992","journal-title":"Pediatrics."},{"key":"2021121003001637500_B17","first-page":"658","article-title":"Follow-up of preterm infants treated with dexamethasone for chronic lung disease.","volume":"147","author":"O'Shea","year":"1993","journal-title":"Am J Dis Child."},{"key":"2021121003001637500_B18","first-page":"178","article-title":"Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy.","volume":"15","author":"Ramanathan","year":"1995","journal-title":"J Perinatol."},{"key":"2021121003001637500_B19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-2007-994360","article-title":"Response to dexamethasone in ventilated preterm infants: effect of radiographic subtype of chronic lung disease.","volume":"13","author":"Kothadia","year":"1996","journal-title":"Am J Perinatol."},{"key":"2021121003001637500_B20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1542\/peds.97.6.818","article-title":"Cardiac effects of dexamethasone in very low birth weight infants.","volume":"97","author":"Bensky","year":"1996","journal-title":"Pediatrics."},{"key":"2021121003001637500_B21"},{"key":"2021121003001637500_B22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/adc.64.4_Spec_No.448","article-title":"The changing pattern of chronic lung disease of prematurity.","volume":"64","author":"Hyde","year":"1989","journal-title":"Arch Dis Child."},{"key":"2021121003001637500_B23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF02456282","article-title":"Persistent pulmonary abnormalities in newborns: the changing picture of bronchopulmonary dysplasia.","volume":"16","author":"Heneghan","year":"1986","journal-title":"Pediatr Radiol."},{"key":"2021121003001637500_B24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1542\/peds.74.1.127","article-title":"An international classification of retinopathy of prematurity.","volume":"74","author":"Committee on An International Classification of Retinopathy of Prematurity","year":"1984","journal-title":"Pediatrics."},{"key":"2021121003001637500_B25"},{"key":"2021121003001637500_B26"},{"key":"2021121003001637500_B27"},{"key":"2021121003001637500_B28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/adc.67.1_Spec_No.10","article-title":"Dexamethasone treatment during ventilator dependency: possible life threatening gastrointestinal complications.","volume":"67","author":"O'Neal","year":"1992","journal-title":"Arch Dis Child."},{"key":"2021121003001637500_B29","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/adc.66.10_Spec_No.1164","article-title":"Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia.","volume":"66","author":"Ng","year":"1991","journal-title":"Arch Dis Child."},{"key":"2021121003001637500_B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/adc.67.1_Spec_No.1","article-title":"Catabolic effect of dexamethasone in the preterm baby.","volume":"67","author":"Brownlee","year":"1992","journal-title":"Arch Dis Child."},{"key":"2021121003001637500_B31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/adc.69.5_Spec_No.505","article-title":"Growth retardation after dexamethasone administration: assessment by knemometry.","volume":"69","author":"Gibson","year":"1993","journal-title":"Arch Dis Child."},{"key":"2021121003001637500_B32","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199804163381604","article-title":"A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants.","volume":"338","author":"Papile","year":"1998","journal-title":"N Engl J Med."},{"key":"2021121003001637500_B33"},{"key":"2021121003001637500_B34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1542\/peds.88.2.413","article-title":"The use of dexamethasone in premature infants at risk for bronchopulmonary dysplasia of who already have developed chronic lung disease: a cautionary note.","volume":"88","author":"Frank","year":"1991","journal-title":"Pediatrics."},{"key":"2021121003001637500_B35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0022-3476(95)70464-7","article-title":"Twenty-month outcome in ventilator-dependent, very low birth weight infants born during the early years of dexamethasone therapy.","volume":"126","author":"Furman","year":"1995","journal-title":"J Pediatr."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/104\/1\/22\/842267\/22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/104\/1\/22\/842267\/22.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T07:34:56Z","timestamp":1734507296000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/104\/1\/22\/62490\/Randomized-Placebo-controlled-Trial-of-a-42-Day"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1999,7,1]]},"published-print":{"date-parts":[[1999,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.104.1.22","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[1999,7,1]]}}}